Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ · Healthcare
Vanda Pharmaceuticals Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Vanda Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 161.8M, a 37.48% increase year-over-year.
- Vanda Pharmaceuticals Inc. total liabilities for 2025 were 161.8M, a 37.48% increase from 2024.
- Vanda Pharmaceuticals Inc. total liabilities for 2024 were 117.7M, a 13.65% increase from 2023.
- Vanda Pharmaceuticals Inc. total liabilities for 2023 were 103.5M, a 3.29% decrease from 2022.
- Vanda Pharmaceuticals Inc. total liabilities for 2022 were 107.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Vanda Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $162 |
| 2024 | $118 |
| 2023 | $104 |
| 2022 | $107 |
| 2021 | $89 |
| 2020 | $80 |
| 2019 | $73 |
| 2018 | $57 |
| 2017 | $74 |
| 2016 | $79 |
| 2015 | $80 |
| 2014 | $11 |
| 2013 | $99 |
| 2012 | $126 |
| 2011 | $149 |
| Vanda Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $162 |
| 2024-12-31 | $118 |
| 2023-12-31 | $104 |
| 2022-12-31 | $107 |
| 2021-12-31 | $89 |
| 2020-12-31 | $80 |
| 2019-12-31 | $73 |
| 2018-12-31 | $57 |
| 2017-12-31 | $74 |
| 2016-12-31 | $79 |
| 2015-12-31 | $80 |
| 2014-12-31 | $11 |
| 2013-12-31 | $99 |
| 2012-12-31 | $126 |
| 2011-12-31 | $149 |
| 2010-12-31 | $175 |
Vanda Pharmaceuticals Inc. Total Liabilities — FAQ
Vanda Pharmaceuticals Inc. (VNDA) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VNDA's total liabilities history?
The chart and table above show Vanda Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.